Collegium Pharmaceutical (COLL) Current Leases (2019 - 2026)

Collegium Pharmaceutical's Current Leases history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Current Leases rose 11.12% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 11.12% YoY), while the FY2025 annual figure was $1.4 million, up 10.7% from the prior year.
• Current Leases was $1.4 million for Q1 2026 at Collegium Pharmaceutical, up from $1.4 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.4 million in Q1 2026 to a low of $963000.0 in Q3 2023.
• Historically, Current Leases has averaged $1.2 million across 5 years, with a median of $1.2 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Current Leases soared 57.07% in 2022, then fell 19.82% in 2023.
• A 5-year view of Current Leases shows it stood at $1.1 million in 2022, then fell by 11.15% to $988000.0 in 2023, then increased by 28.64% to $1.3 million in 2024, then gained by 10.7% to $1.4 million in 2025, then rose by 2.99% to $1.4 million in 2026.
• The last three Current Leases figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.